Healthtech unicorn Biofourmis is reportedly carrying out a second round of layoffs, which will affect roughly 45 employees in Singapore and a minimum of 85 staff members globally.

This move follows the firm’s job cuts three months ago, which saw about 120 employees axed. The company also plans to vacate its Singapore office by December and shift its employees there to a work from home set up.